|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
JPS5721312A
(en)
*
|
1980-07-12 |
1982-02-04 |
Green Cross Corp:The |
Breathable ointment
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
JPH0764702B2
(ja)
|
1986-04-23 |
1995-07-12 |
鐘紡株式会社 |
多相乳化型化粧料
|
|
JPH03279323A
(ja)
|
1989-12-15 |
1991-12-10 |
Johnson & Johnson Consumer Prod Inc |
日焼け止め組成物
|
|
JP3046346B2
(ja)
|
1990-03-12 |
2000-05-29 |
昭和電工株式会社 |
外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US5152997A
(en)
|
1990-12-11 |
1992-10-06 |
Theratech, Inc. |
Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
DE4405627A1
(de)
*
|
1994-02-22 |
1995-08-24 |
Hoechst Ag |
Fluorkohlenwasserstoffe enthaltende Ölemulsionen
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
DE19536504C2
(de)
*
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
RU2111738C1
(ru)
|
1996-06-24 |
1998-05-27 |
Акционерное общество "НИЗАР" |
Средство для усиления солнцезащитной активности фотозащитных агентов
|
|
FR2752161B1
(fr)
|
1996-08-07 |
1998-09-25 |
Atta |
Emulsions multiples de type hydrocarbure-dans-eau-dans- fluorocarbone pour le transport de substances medicamenteuses hydrophiles et/ou lipophiles
|
|
US5863560A
(en)
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
DK0983037T3
(da)
|
1998-02-09 |
2003-09-01 |
Macrochem Corp |
Fungicid neglelak
|
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
|
EP1152749B1
(en)
|
1999-02-08 |
2006-04-12 |
ALZA Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
US6528086B2
(en)
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
|
US20060204458A1
(en)
|
2000-10-26 |
2006-09-14 |
Holloway William D Jr |
Anti-aging methods and composition
|
|
DE10024413A1
(de)
|
2000-05-19 |
2001-12-06 |
Mika Pharma Gmbh |
Pharmazeutische und/oder kosmetische Zubereitung
|
|
DE10042412B4
(de)
|
2000-08-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
|
|
WO2002089849A1
(en)
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
DE60223694T2
(de)
|
2001-09-04 |
2008-10-30 |
Trommsdorff Gmbh & Co. Kg Arzneimittel |
Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
|
|
US20050084553A1
(en)
|
2002-01-26 |
2005-04-21 |
Woong-Sig Moon |
Composition containing moutan root bark extract as active ingredient
|
|
EP1663148A2
(en)
|
2003-08-25 |
2006-06-07 |
Foamix Ltd. |
Penetrating pharmaceutical foam
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
DK1670433T3
(da)
|
2003-10-10 |
2012-03-12 |
Ferring Bv |
Transdermal farmaceutisk formulering til mindskelse af hudrester
|
|
JP2007511616A
(ja)
|
2003-11-19 |
2007-05-10 |
バーンズ−ジューイッシュ ホスピタル |
増強された薬物送達
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
WO2005099718A1
(en)
|
2004-04-19 |
2005-10-27 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Lung surfactant supplements
|
|
JP2008501806A
(ja)
|
2004-06-08 |
2008-01-24 |
オキュラリス ファーマ， インコーポレイテッド |
疎水性眼用組成物および使用方法
|
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
|
FR2892023B1
(fr)
|
2005-10-14 |
2009-09-25 |
Galderma Sa |
Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
|
|
DE102005050431A1
(de)
|
2005-10-21 |
2007-04-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
|
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
AU2008300013A1
(en)
|
2007-09-07 |
2009-03-19 |
Qlt Inc. |
Drug cores for sustained release of therapeutic agents
|
|
EP2110126B9
(de)
|
2008-04-18 |
2012-09-19 |
Novaliq GmbH |
Inhalative und instillative Verwendung von semifluorierten Alkanen als Wirkstoffträger im intrapulmonalen Bereich
|
|
SI2387391T1
(sl)
|
2009-07-24 |
2017-04-26 |
Mika Pharma Gesellschaft Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh |
Postopek za pripravo tekočega sestavka, ki se nanaša na kožo v obliki pene, in sestavka, ki se lahko nanaša topično
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
WO2011113855A2
(en)
|
2010-03-17 |
2011-09-22 |
Novaliq Gmbh |
Pharmaceutical composition for treatment of increased intraocular pressure
|
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
HUP1000362A2
(en)
|
2010-07-12 |
2012-11-28 |
Egis Gyogyszergyar Nyrt |
Antiseptic and disinfecting compositions having reduced iodine content
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
US20120100183A1
(en)
|
2010-10-23 |
2012-04-26 |
Joel Schlessinger |
Topical base and active agent-containing compositions, and methods for improving and treating skin
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
DK2661280T3
(en)
|
2011-01-04 |
2019-03-04 |
Novaliq Gmbh |
O / V EMULSIONS INCLUDING SEMIFLUORINATED ALKANES
|
|
US20120219640A1
(en)
|
2011-02-25 |
2012-08-30 |
Wright Kenneth W |
Anti-infective solution for athlete's foot
|
|
CN107397718A
(zh)
*
|
2011-05-25 |
2017-11-28 |
诺瓦利克有限责任公司 |
基于半氟化烷烃类的外用药物组合物
|
|
KR101773648B1
(ko)
|
2011-05-25 |
2017-08-31 |
노바리크 게엠베하 |
조갑에 투여를 위한 제약학적 조성물
|
|
US8758826B2
(en)
|
2011-07-05 |
2014-06-24 |
Wet Inc. |
Cannabinoid receptor binding agents, compositions, and methods
|
|
KR101989648B1
(ko)
|
2012-01-23 |
2019-06-14 |
노바리크 게엠베하 |
부분불소화 알칸에 기초한 안정화된 단백질 조성물
|
|
EP2863888A1
(en)
*
|
2012-06-25 |
2015-04-29 |
Bayer HealthCare LLC |
Topical ophthalmological pharmaceutical composition containing axitinib
|
|
DK3181119T3
(da)
|
2012-09-12 |
2019-09-16 |
Novaliq Gmbh |
Semifluorerede alkansammensætninger til anvendelse ved behandling af keratoconjunctivitis sicca
|
|
CN113679697A
(zh)
|
2012-09-12 |
2021-11-23 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
BR112016001522B1
(pt)
|
2013-07-23 |
2019-10-01 |
Novaliq Gmbh |
Composições de anticorpo estabilizado
|
|
EP2944324A1
(de)
*
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
|
US9186305B1
(en)
|
2014-05-19 |
2015-11-17 |
Shiseido Company, Ltd. |
Sunscreen products in which excessive whiteness due to titanium dioxide and zinc oxide is visually masked upon skin application
|
|
MX2018003781A
(es)
|
2015-09-30 |
2018-09-12 |
Novaliq Gmbh |
Compuestos semifluorados para administracion oftalmica.
|
|
CN108348777B
(zh)
|
2015-09-30 |
2020-04-28 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
CA2983765C
(en)
|
2016-06-08 |
2018-02-27 |
Majda Ficko |
Sun block formulation
|
|
USRE50060E1
(en)
|
2016-06-23 |
2024-07-30 |
Novaliq Gmbh |
Topical administration method
|
|
CN106176937A
(zh)
*
|
2016-08-24 |
2016-12-07 |
刘艺鹏 |
湿疹、痤疮软膏
|
|
CA3058097C
(en)
*
|
2017-04-21 |
2024-01-02 |
Novaliq Gmbh |
Iodine compositions
|
|
US20210069014A1
(en)
|
2017-05-06 |
2021-03-11 |
Novaliq Gmbh |
Drop dispenser
|
|
WO2020064556A1
(en)
|
2018-09-27 |
2020-04-02 |
Novaliq Gmbh |
Topical sunscreen formulation
|
|
IL283357B2
(en)
|
2018-11-27 |
2025-05-01 |
Novaliq Gmbh |
Semifluorinated alkane preparations containing omega-3 fatty acid ethyl esters
|
|
EP3861857A1
(en)
|
2020-02-07 |
2021-08-11 |
Novaliq GmbH |
Antiparasitic compositions
|